As a clinician and a scientist, could you comment on the respective contributions of clinical (individual) and population-based approaches to prevent/manage type 2 diabetes?

Nicholas J. Wareham, MB, PhD, Professor and Director, MRC Epidemiology Unit, University of Cambridge, Cambridge, UK